当前位置：Public Access >页面
Chinese/English
Prospective, randomized, controlled phase II clinical study of LDRT+SBRT to reverse resistance to first-line PD(L)-1 monoclonal antibody combination therapy in driver-negative stage IV non-small cell lung cancer
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。

提示：推荐使用chrome浏览器 并且在宽屏显示分辨率下使用系统。

Copyright(c) (2010-2013) .All rights reserved.临床试验公共管理平台 版权所有